Robeco Institutional Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Robeco Institutional Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261M	Buy	18,021,100 +843,218	+5%	+$11.4M	0.32%	70
2026 Q1	$238M	Buy	17,177,882 +4,023,358	+31%	+$56M	0.34%	71
2025 Q4	$185M	Buy	13,154,524 +70,018	+0.5%	+$982K	0.26%	93
2025 Q3	$183M	Buy	13,084,506 +921,078	+8%	+$13.3M	0.27%	93
2025 Q2	$183M	Buy	12,163,428 +1,452,192	+14%	+$20.7M	0.3%	80
2025 Q1	$141M	Sell	10,711,236 -727,672	-6%	-$10M	0.27%	84
2024 Q4	$181M	Buy	11,438,908 +1,111,428	+11%	+$16.7M	0.34%	60
2024 Q3	$164M	Sell	10,327,480 -18,675	-0.2%	-$301K	0.33%	65
2024 Q2	$158M	Buy	10,346,155 +472,555	+5%	+$6.77M	0.34%	62
2024 Q1	$145M	Buy	9,873,600 +1,246,700	+14%	+$18.2M	0.31%	72
2023 Q4	$120M	Buy	8,626,900 +261,270	+3%	+$3.49M	0.29%	82
2023 Q3	$112M	Buy	8,365,630 +1,093,025	+15%	+$14.8M	0.3%	82
2023 Q2	$91.8M	Buy	7,272,605 +1,996,920	+38%	+$23.3M	0.24%	99
2023 Q1	$60.1M	Buy	5,275,685 +859,375	+19%	+$9.28M	0.16%	148
2022 Q4	$45.7M	Buy	+4,416,310	New	+$47.6M	0.13%	176

Other funds holding RDY

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWM

Venturi Wealth Management Austin, Texas $2.58B AUM 41.25% 1-Year Est. Return

Robeco Institutional Asset Management's RDY Position: Q2 2026 in Review

Robeco Institutional Asset Management increased its Dr. Reddy's Laboratories (RDY) stake by 4.9% in Q2 2026, buying an estimated $11.4M and bringing the position to 18,021,100 shares worth $261M. The position accounts for 0.32% of the portfolio, ranked #70.

Robeco Institutional Asset Management first reported a position in RDY in Q4 2022 and has held it in 15 quarters since. 41 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Robeco Institutional Asset Management held 18,021,100 shares of Dr. Reddy's Laboratories worth $261M as of Q2 2026.
Robeco Institutional Asset Management bought 843,218 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $11.4M.
Dr. Reddy's Laboratories made up 0.32% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #70 holding.
Robeco Institutional Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2022 and has held it in 15 quarters since.
41 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.